Stroke and aging;Accident vasculaire cérébral du sujet âgé

Revue Medicale de Liege

Volumn 69, Issue 5-6, 2014, Pages 315-317

  Ly, J ^a,b   Maquet, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b FNRS   (Belgium)

Author keywords

Ischemic stroke; Stroke; Stroke unit; Thrombolysis; Very elderly

Indexed keywords

AGING; ARTICLE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; FUNCTIONAL STATUS; HUMAN; MORBIDITY; MORTALITY; RISK FACTOR; SEX RATIO; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; FEMALE; HUMANS; MALE; RISK FACTORS; SEX RATIO; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84903768147     PISSN: 0370629X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Markus H, Pereirz A, Cloud G. - Stroke Medicine. Oxford Spe. Oxford : Oxford University Press Inc., New York. 2010, 1-49.
2. Di Carlo A, Lamassa M, Pracucci G, et al. - Stroke in the very old?: clinical presentation and determinants of 3-month functional outcome : a European perspective. European BIOMED Study of Stroke Care Group. Stroke, 1999, 30, 2313-2319. (Pubitemid 29517728)
3. Fonarow GC, Reeves MJ, Zhao X, et al. - Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation, 2010, 121, 879-891.
4. Bentsen L, Christensen L, Christensen A, et al. - Outcome and risk factors presented in old patients above 80 years of age versus younger patients after ischemic stroke. J Stroke Cerebrovasc Dis, 2014, 16, 1-5.
5. Denti L, Scoditti U, Tonelli C, et al. - The poor outcome of ischemic stroke in very old people : a cohort study of its determinants. J Am Geriatr Soc, 2010, 58, 12-17.
6. Busl KM, Nogueira RG, Yoo AJ, et al. - Prestroke dementia is associated with poor outcomes after reperfusion therapy among elderly stroke patients. J Stroke Cerebrovasc Dis, 2013, 22, 718-724.
7. Arsava EM, Vural A, Akpinar E, et al. - The detrimental effect of aging on leptomeningeal collaterals in ischemic stroke. J Stroke Cerebrovasc Dis, 2014, 23, 421-426.
8. Ribo M, Flores A, Mansilla E, et al. - Age-adjusted infarct volume threshold for good outcome after endovascular treatment. J Neurointerv Surg, 2013.
9. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B et al. - Predictors of in-hospital mortality and attributable risks of death after ischemic stroke : the german stroke registers study group. Arch Intern Med, 2004, 164, 1761-1768. (Pubitemid 39215645)
10. Stroke Unit Trialists' Collaboration. - Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev, 2007, 17, CD000197.
11. Silvestrelli G, Parnetti L, Paciaroni M, et al. - Early admission to stroke unit influences clinical outcome. Eur J Neurol, 2006, 13, 250-255.
12. Recommandations HAS. - Accident vasculaire cérébral? : prise en charge précoce. 2009.
13. Tissue plasminogen activator for acute ischemic stroke. - The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med, 1995, 333, 1581-1587.
14. Hacke W, Kaste M, Bluhmki E, et al. - Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med, 2008, 359, 1317-1329.
15. Kernan WN, Ovbiagele B, Black HR, et al. - Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack : a guideline for healthcare professionals drom the american heart association/american stroke association. Stroke, 2014.
16. Samson Y. - Étendre les indications de la thrombolyse. Neurologie, 2009, 1, 205.
17. Suissa L. - Journées de neurologie de langue française. Atelier. Conduite à tenir devant un infarctus cérébral à la phase aiguë. Nice. 4 avril 2012.
18. Sandercock P, Wardlaw JM, Lindley RI, et al. - The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial (IST-3)) : a randomised controlled trial. Lancet, 2012, 379, 2352-2363.
19. Berrouschot J, Röther J, Glahn J, et al. - Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients. Stroke, 2005, 36, 2421-2425. (Pubitemid 41566970)